Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.61 and traded as low as $0.40. Eagle Pharmaceuticals shares last traded at $0.90, with a volume of 3,517 shares trading hands.
Eagle Pharmaceuticals Stock Down 30.0%
The firm’s fifty day simple moving average is $0.62 and its 200-day simple moving average is $0.50. The firm has a market capitalization of $11.69 million, a PE ratio of 0.76 and a beta of 0.83.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc is a specialty pharmaceutical company focused on developing, manufacturing and commercializing injectable products for use in hospital and other acute-care settings. The company’s portfolio includes branded products, ready-to-use formulations and therapies designed to address clinical or logistical challenges associated with existing medicines.
Eagle’s marketed products have included Ryanodex (dantrolene sodium), an emergency treatment for malignant hyperthermia; Belrapzo (bendamustine hydrochloride), used in certain blood cancers; Pemfexy (pemetrexed), a chemotherapy treatment; Barhemsys (amisulpride), used to prevent and treat postoperative nausea and vomiting; and Byfavo (remimazolam), an intravenous sedative used for procedural sedation.
Further Reading
- Five stocks we like better than Eagle Pharmaceuticals
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
